Bielefeld University at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Bielefeld University brings 7 presentations to ESGCT 2026 in Hamburg. Its work centres on how AAV particles assemble and package DNA, with nanobodies and energy-transfer imaging used to follow the process. Other strands test AAV therapy in models of peroxisomal and lysosomal disease, Parkinson's and inherited cardiomyopathy.
| Organization | ESGCT 2026 Attendance |
|---|---|
Bielefeld University Bielefeld, Germany | |
Poster Wed Oct 28 1:30pm–3:30pm Recombinant AAV encapsidation of DNA in chemically defined conditions yields functional particles Poster Wed Oct 28 1:30pm–3:30pm Recombinant adeno-associated virus restore peroxisomal import in PEX10-deficient human cell lines Poster Wed Oct 28 1:30pm–3:30pm α-Synu-Clear: towards a genetically encoded degrader system for alpha-synuclein in Parkinson’s disease Poster Thu Oct 29 2:00pm–4:00pm AAV-mediated gene therapy as a promising treatment strategy in a fucosidosis mouse model Rare and inherited diseaseVectors and delivery (AAV, lentiviral, LNP) Poster Thu Oct 29 2:00pm–4:00pm AAV4Desmin: Characterization of clustered cardiomyopathy-associated desmin mutations and insights towards a potential gene therapeutic approach Poster Thu Oct 29 2:00pm–4:00pm Prokaryotic Production of a Pan-Serotype Adeno-Associated Virus–Binding Nanobody for Detection, Quantification, and Purification Poster Thu Oct 29 2:00pm–4:00pm Spatial-temporal monitoring of AAV capsid assembly by AP-FRET and live cell FLIM-FRET |
Instantly find 20 buyers from Bielefeld University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction